Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy

This publication has 24 references indexed in Scilit:

• Efficacy and safety of extended‐release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial‐onset seizures: a randomized controlled trial
  Acta Neurologica Scandinavica, 2013
• Central nervous system adverse effects of new antiepileptic drugs
  Seizure: European Journal of Epilepsy, 2008
• Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy
  Epilepsy Research, 2006
• Clinical Pharmacokinetics of Oxcarbazepine
  Clinical Pharmacokinetics, 2003
• Marketed New Antiepileptic Drugs: Are They Better Than Old-Generation Agents?
  Therapeutic Drug Monitoring, 2002
• Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures
  Neurology, 2001
• Oxcarbazepine Placebo‐Controlled, Dose‐Ranging Trial in Refractory Partial Epilepsy
  Epilepsia, 2000
• Therapeutic monitoring of the new antiepileptic drugs
  European Journal of Clinical Pharmacology, 2000
• Serumkonzentration von Antiepileptika Praktische Richtlinien zur Messung und sinnvollen Interpretation
  Der Nervenarzt, 1999
• Oxcarbazepine in treatment of childhood epilepsy: A survey of 46 children and adolescents
  Journal of Epilepsy, 1998